The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours

BJU International

Volumn 91, Issue 6, 2003, Pages 469-473

  McGuire, M S ^a,d   Rabbani, F ^a,b   Mohseni, H ^a,c   Bains, M ^a,b   Motzer, R ^a,b   Sheinfeld, J ^a,b  

^a Division of Urology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Nonseminomatous germ cell cancer; Testis cancer; Thoracotomy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; PLATINUM; VINBLASTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; DISEASE ASSOCIATION; EVALUATION; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; OBESITY; ONCOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; THORACOTOMY; THORAX TUMOR; TREATMENT OUTCOME; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; MALE; ODDS RATIO; PROGNOSIS; TESTICULAR NEOPLASMS; THORACIC NEOPLASMS; THORACOTOMY;

EID: 0038215393     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04128.x     Document Type: Article

References (11)

1. Steyerberg EW, Donohue JP, Gerl A et al. Residual masses after chemotherapy for metastatic testicular cancer. The clinical implications of the association between retroperitoneal and pulmonary histology. J Urol 1997; 158: 474-8
2. Tognini PG, Foster RS, McGraw P et al. Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology. J Urol 1998; 159: 1833-5
3. Tiffany P, Morse MJ, Bosl G et al. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors. Cancer 1986; 57: 978-83
4. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15: 594-603
5. Donohue JP, Rowland RG, Kopecky K et al. Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 1987; 137: 1176-9
6. Brenner PC, Herr HW, Morse MJ et al. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic, nonseminomatous germ cell tumors of the testis. J Clin Oncol 1996; 14: 1765-9
7. Hartmann JT, Candelaria M, Kuczyk MA, Schmoll H-J, Bokemeyer C. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumors. Eur J Cancer 1997; 33: 843-7
8. Mandelbaum I, Yaw PB, Einhorn LH, Williams SD, Rowland RG, Donohue JP. The importance of one-stage sternotomy and retroperitoneal node dissection in disseminated testicular cancer. Ann Thor Surg 1983; 36: 524-8
9. Steyerberg EW, Keizer HJ, Messemer JE et al. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. Cancer 1997; 79: 345-55
10. Gels ME, Hoekstra HJ, Sleijfer DT et al. Thoracotomy for post-chemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified. Chest 1997; 112: 967-73
11. Sheinfeld J, Herr HW. Role of surgery in management of germ cell tumor. Seminars Oncol 1998; 25: 203-9